FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2564852021> ?p ?o ?g. }

• W2564852021 endingPage "1662" @default.
• W2564852021 startingPage "1662" @default.
• W2564852021 abstract "Abstract Childhood myelodysplastic syndromes (MDS) belong to a rare group of disorders of aberrant clonal hematopoiesis manifesting throughout entire childhood and adolescence. We had previously established that GATA2 germline mutations can be considered the most common first hit in pediatric MDS seen in 7% of primary MDS. However the secondary somatic aberrations facilitating leukemogenesis are not elucidated in children. Previous sequencing efforts established that most somatic mutations very frequently encountered in adults, i.e. affecting TET2, DNMT3a, and the spliceosome genes, do not play a role in the pathogenesis of childhood MDS. Here we aim to define the global mutational landscape in childhood MDS using targeted next-generation sequencing (NGS) approaches. We investigated children and adolescents enrolled in the prospective studies of the European Working Group of Childhood MDS. Diverse target enrichment and NGS strategies were established including hybridization capture and Ampliseq PCR, Illumina Miseq/Hiseq and Iontorrent PGM. We first examined a pilot cohort of 68 patients for mutations in 138 myeloid leukemia genes. This allowed for the identification of recurrently mutated genes that were selected to be included in a pediatric MDS panel encompassing 28 genes. Targeted NGS using the Iontorrent PGM identified known recurrent mutations. However, the high indel error rate and coverage gaps in homopolymeric regions i.e. in ASXL1 precluded further studies. Using inhouse-adapted Ampliseq-Miseq approach we then sequenced DNA from bone marrow of 586 MDS patients (469 primary and 117 secondary MDS after radio/chemotherapy or inherited bone marrow failure syndromes) at an average depth exceeding 700 reads per amplicon. Somatic mutations were identified in 22% of primary MDS patients, with 1, 2 and 3 genes affected in 16%, 4.5%, and 1.5% of cases, respectively. In secondary MDS twice as many patients (46%) carried mutations; 1, 2, and 3 genes were concurrently mutated in 32.5%, 9.5%, and 4% of patients, respectively. Longitudinal NGS analyses and single CFU colony sequencing confirmed the presence of multiple somatic clones evolving in a hierarchical manner throughout disease course. Most frequent mutations identified in more than 1% of our study cohort of primary MDS were: SETBP1 (7%), ASXL1 (6%), NRAS/KRAS (5%), RUNX1 (3%), PTPN11 (3%) and BCOR/BCORL (1.5%); and in secondary MDS: RUNX1 (14.5%), TP53 (9%), NRAS/KRAS (8.5%), ASXL1 (8%), SETBP1 (6%), PTPN11 (6%), CBL (5%), BCOR/BCORL1 (3.4%). Other genes mutated at very low frequency of <1% were CTCF, STAG2, RAD21, PTEN, JAK3, FLT3, CSF3R, and EZH2. No somatic mutations were identified in CEBPA, GATA1, GATA2, JAK2, cKIT, VPS45, MPL, CALR, SH2B3. The analysis of individual mutational clusters established that for some mutations strongly associate with monosomy 7; i.e. this cytogenetic subgroup was prevalent in 100% of EZH2, 90% of SETBP1, 79% of RUNX1, and 74% of ASXL1 - mutated children with MDS In conclusion, we established and cross-platform validated a targeted NGS-panel for pediatric MDS, allowing to identify clonal mutations at a sensitivity of at least 10%. In this, to our knowledge largest systematicaly studied cohort of children with MDS we show that mutational load and clonal complexity differs between primary and secondary MDS, and maintains specific patterns for monosomy 7. Although the biological significance of these genomic changes is currently not understood, the emerging distinctive patterns may already be helpful in establishing therapeutic subgroups. Disclosures No relevant conflicts of interest to declare." @default.
• W2564852021 created "2017-01-06" @default.
• W2564852021 creator A5003219667 @default.
• W2564852021 creator A5003429770 @default.
• W2564852021 creator A5003872799 @default.
• W2564852021 creator A5009599576 @default.
• W2564852021 creator A5010331268 @default.
• W2564852021 creator A5016203121 @default.
• W2564852021 creator A5019842450 @default.
• W2564852021 creator A5022299669 @default.
• W2564852021 creator A5022712318 @default.
• W2564852021 creator A5027489479 @default.
• W2564852021 creator A5029280043 @default.
• W2564852021 creator A5035945818 @default.
• W2564852021 creator A5037374709 @default.
• W2564852021 creator A5037934940 @default.
• W2564852021 creator A5038121748 @default.
• W2564852021 creator A5039379107 @default.
• W2564852021 creator A5042469434 @default.
• W2564852021 creator A5044116082 @default.
• W2564852021 creator A5045088100 @default.
• W2564852021 creator A5045175580 @default.
• W2564852021 creator A5052986225 @default.
• W2564852021 creator A5057818328 @default.
• W2564852021 creator A5059496734 @default.
• W2564852021 creator A5062188329 @default.
• W2564852021 creator A5062522556 @default.
• W2564852021 creator A5071534196 @default.
• W2564852021 creator A5076697510 @default.
• W2564852021 creator A5084786036 @default.
• W2564852021 creator A5085568642 @default.
• W2564852021 creator A5085974329 @default.
• W2564852021 date "2015-12-03" @default.
• W2564852021 modified "2023-10-18" @default.
• W2564852021 title "Clonal Mutational Landscape of Childhood Myelodysplastic Syndromes" @default.
• W2564852021 doi "https://doi.org/10.1182/blood.v126.23.1662.1662" @default.
• W2564852021 hasPublicationYear "2015" @default.
• W2564852021 type Work @default.
• W2564852021 sameAs 2564852021 @default.
• W2564852021 citedByCount "7" @default.
• W2564852021 countsByYear W25648520212017 @default.
• W2564852021 countsByYear W25648520212018 @default.
• W2564852021 countsByYear W25648520212022 @default.
• W2564852021 countsByYear W25648520212023 @default.
• W2564852021 crossrefType "journal-article" @default.
• W2564852021 hasAuthorship W2564852021A5003219667 @default.
• W2564852021 hasAuthorship W2564852021A5003429770 @default.
• W2564852021 hasAuthorship W2564852021A5003872799 @default.
• W2564852021 hasAuthorship W2564852021A5009599576 @default.
• W2564852021 hasAuthorship W2564852021A5010331268 @default.
• W2564852021 hasAuthorship W2564852021A5016203121 @default.
• W2564852021 hasAuthorship W2564852021A5019842450 @default.
• W2564852021 hasAuthorship W2564852021A5022299669 @default.
• W2564852021 hasAuthorship W2564852021A5022712318 @default.
• W2564852021 hasAuthorship W2564852021A5027489479 @default.
• W2564852021 hasAuthorship W2564852021A5029280043 @default.
• W2564852021 hasAuthorship W2564852021A5035945818 @default.
• W2564852021 hasAuthorship W2564852021A5037374709 @default.
• W2564852021 hasAuthorship W2564852021A5037934940 @default.
• W2564852021 hasAuthorship W2564852021A5038121748 @default.
• W2564852021 hasAuthorship W2564852021A5039379107 @default.
• W2564852021 hasAuthorship W2564852021A5042469434 @default.
• W2564852021 hasAuthorship W2564852021A5044116082 @default.
• W2564852021 hasAuthorship W2564852021A5045088100 @default.
• W2564852021 hasAuthorship W2564852021A5045175580 @default.
• W2564852021 hasAuthorship W2564852021A5052986225 @default.
• W2564852021 hasAuthorship W2564852021A5057818328 @default.
• W2564852021 hasAuthorship W2564852021A5059496734 @default.
• W2564852021 hasAuthorship W2564852021A5062188329 @default.
• W2564852021 hasAuthorship W2564852021A5062522556 @default.
• W2564852021 hasAuthorship W2564852021A5071534196 @default.
• W2564852021 hasAuthorship W2564852021A5076697510 @default.
• W2564852021 hasAuthorship W2564852021A5084786036 @default.
• W2564852021 hasAuthorship W2564852021A5085568642 @default.
• W2564852021 hasAuthorship W2564852021A5085974329 @default.
• W2564852021 hasConcept C104317684 @default.
• W2564852021 hasConcept C113968399 @default.
• W2564852021 hasConcept C13514818 @default.
• W2564852021 hasConcept C143998085 @default.
• W2564852021 hasConcept C203014093 @default.
• W2564852021 hasConcept C2780007613 @default.
• W2564852021 hasConcept C2780817109 @default.
• W2564852021 hasConcept C501734568 @default.
• W2564852021 hasConcept C54355233 @default.
• W2564852021 hasConcept C71924100 @default.
• W2564852021 hasConcept C86803240 @default.
• W2564852021 hasConceptScore W2564852021C104317684 @default.
• W2564852021 hasConceptScore W2564852021C113968399 @default.
• W2564852021 hasConceptScore W2564852021C13514818 @default.
• W2564852021 hasConceptScore W2564852021C143998085 @default.
• W2564852021 hasConceptScore W2564852021C203014093 @default.
• W2564852021 hasConceptScore W2564852021C2780007613 @default.
• W2564852021 hasConceptScore W2564852021C2780817109 @default.
• W2564852021 hasConceptScore W2564852021C501734568 @default.
• W2564852021 hasConceptScore W2564852021C54355233 @default.
• W2564852021 hasConceptScore W2564852021C71924100 @default.
• W2564852021 hasConceptScore W2564852021C86803240 @default.
• W2564852021 hasIssue "23" @default.

• next